Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001.
about
Are we there yet? The smallpox research agenda using variola virusHuman MonkeypoxA cutting-edge view on the current state of antiviral drug development.Effects of nasal or pulmonary delivered treatments with an adenovirus vectored interferon (mDEF201) on respiratory and systemic infections in mice caused by cowpox and vaccinia viruses.Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless micePostchallenge administration of brincidofovir protects healthy and immune-deficient mice reconstituted with limited numbers of T cells from lethal challenge with IHD-J-Luc vaccinia virus.Effects of postchallenge administration of ST-246 on dissemination of IHD-J-Luc vaccinia virus in normal mice and in immune-deficient mice reconstituted with T cellsEfficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox).Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012.Comparison of three dimensional synergistic analyses of percentage versus logarithmic data in antiviral studies.ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping.Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the Ugly.Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity.Are We Prepared in Case of a Possible Smallpox-Like Disease Emergence?The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak.
P2860
Q21131362-F823B332-9987-4745-8B26-1F45D274CEBDQ27023061-E12B2464-8DAE-4022-9C1C-C4ABA362EA66Q34036018-5C0C605D-FFDD-4869-8C94-987912D418D8Q34850450-6AB1E658-3846-4B0B-95F5-48242E6C41DCQ34922842-D03B8292-0EC2-4580-8A86-C98180C8C770Q35110971-7F3E0410-0E6A-4604-AB5A-1EF40007DBC8Q36827391-A78F2407-7499-4677-A181-7CF1607C31D4Q37335688-FC56824A-D58C-4CA0-9665-F31F4A1734A6Q37593480-1686A87C-FC65-449B-9643-F1182C40DAC6Q38694084-463C6B18-EB54-4771-B33D-CF6938B9A39FQ39046951-2D0C814B-E65D-4928-8B15-623AB7E81A54Q42200165-E4D635A7-A5BB-4BDF-9C58-02EDEC9F342AQ45324824-08A2361B-F3DD-4F51-8E19-C52F3FB405EAQ45388494-044A4DBB-680E-451D-A460-64A4F7B63A18Q47116100-15DB53DA-089F-4F3D-B1E9-31F4F6188D66Q47162853-F9E03A70-CC48-4990-BF22-171A70AAAAE1
P2860
Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Progressive vaccinia: case des ...... globulin, ST-246, and CMX001.
@ast
Progressive vaccinia: case des ...... globulin, ST-246, and CMX001.
@en
type
label
Progressive vaccinia: case des ...... globulin, ST-246, and CMX001.
@ast
Progressive vaccinia: case des ...... globulin, ST-246, and CMX001.
@en
prefLabel
Progressive vaccinia: case des ...... globulin, ST-246, and CMX001.
@ast
Progressive vaccinia: case des ...... globulin, ST-246, and CMX001.
@en
P2093
P2860
P356
P1476
Progressive vaccinia: case des ...... globulin, ST-246, and CMX001.
@en
P2093
Dennis E Hruby
Edith R Lederman
Harold L Groff
Inger K Damon
Jeffrey I Cohen
Kevin L Karem
Kimberly A Wilkins
Kimberly L Bergman
Michael Frace
Rafi Ahmed
P2860
P304
P356
10.1093/INFDIS/JIS510
P407
P50
P577
2012-08-16T00:00:00Z